Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium fluoride | HCID 25953 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 2-(Methylsulfinyl)-7-(4-(methylsulfonyl)phenyl)pyrrolo[2,1-f][1,2,4]triazine | HCID 66711046 | — |
| Reactant | HCID 86661694 | HCID 86661694 | — |
| Solvent | tert-Butanol | HCID 6386 | — |
| Product | HCID 86661693 | HCID 86661693 | 32.7% |
Reaction Steps
Into a 8-dram vial, N-(8-Amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)-2,2,2-trifluoro-acetamide (39.4 mg, 0.137 mmol), 2-Methanesulfinyl-7-(4-methanesulfonyl-phenyl)-pyrrolo[2,1-f][1,2,4]triazine (105 mg, 0.313 mmol), Cesium fluoride (41.7 mg, 0.274 mmol), tert-Butyl alcohol (0.80 mL) and N,N-Diisopropylethylamine (0.0478 mL, 0.274 mmol) were added. The reaction mixture was heated at 130° C. overnight. HPLC suggested no starting material. The solvent was evaporated. The reaction mixture was purified via HPLC reverse phase chromatography with 0.1% TFA in Water and 0.1% TFA in ACN. The collected fractions were lyophilized to give 2,2,2-Trifluoro-N-{8-[7-(4-methanesulfonyl-phenyl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl}-acetamide as a yellow solid (25 mg, 32%). LCMS (E/I+) 559.07 (M+H). NMR 1H (DMSO-d6)-9.96 (s, 1H0, 9.74 (s, 1H), 9.65 (bs, 1H), 9.08 (s, 1H), 8.46 (d, 2H, J=7.72 Hz), 8.04 (d, 2H, J=7.72 Hz), 7.59 (s, 1H), 7.54 (d, 1H, J=8.49 Hz), 7.35 (bs, 1H), 7.28 (d, 1H, J=7.72 Hz), 7.03 (d, 1H, J=4.62 Hz), 4.29 (bs, 1H), 3.22 (s, 3H), 2.63-2.72 (m, 2H), 2.24-2.35 (m, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08471005B2 |
|---|
| Source dataset | uspto-grants-2013_06 |
|---|
| ORD ID | ord-8e5e5ec174d945f59c02ae6008c9cb85 |
|---|
| Source note | uspto-grants-2013_06 |
|---|